<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02023437</url>
  </required_header>
  <id_info>
    <org_study_id>1304_3M</org_study_id>
    <nct_id>NCT02023437</nct_id>
  </id_info>
  <brief_title>Long-term (3 Months) Safety of Femtosecond-laser Assisted Cataract Surgery</brief_title>
  <official_title>A Prospective, Post-Market-Clinical-Follow-Up Study to Investigate the Long-term (3 Months) Safety of Femtosecond-laser Assisted Cataract Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Technolas Perfect Vision GmbH</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Technolas Perfect Vision GmbH</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This clinical study is a prospective, post-market-clinical-follow-up study to investigate the
      long-term (3 months) safety of femtosecond laser assisted cataract surgery as a study
      follow-up extension to the Study #1304 titled as &quot;A Multi-centre, Multi-surgeon, Randomized,
      Controlled, Prospective, Post-Market-Clinical-Follow-Up Study to Investigate the Impact of
      Cataract Grade on the Efficacy and Safety of Femtosecond-laser Assisted Lens Fragmentation
      Procedure&quot;.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Actual">March 2014</completion_date>
  <primary_completion_date type="Actual">March 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>3 month</time_frame>
    <description>Less or equal adverse events (e.g. retinal detachment, intraocular lens (IOL) malposition, etc.) in &quot;Laser group&quot; (pooled from all cataract grades) compared with &quot;Manual group&quot; (pooled from all cataract grades); p&lt;0.05 will be considered statistically significant. The primary study end point is only based on adverse events and severe adverse events which are related to the treatment procedures.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">132</enrollment>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>Experimental: Femtosecond laser cataract surgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>&quot;Laser group&quot;: a pre-fragmentation of the ocular lens will be performed by VICTUS femtosecond laser lens fragmentation procedure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Manual cataract surgery</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>&quot;Manual&quot;: manual group acts as a control group where the lens fragmentation are performed manually without femtosecond laser assisted lens fragmentation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Femtosecond laser cataract surgery</intervention_name>
    <description>The VICTUS lens fragmentation procedure is part of the femtosecond laser assisted cataract procedure, which generates precise cuts inside the cataractous lens, leading to a softening and fragmentation of the lens.</description>
    <arm_group_label>Experimental: Femtosecond laser cataract surgery</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Manual cataract surgery</intervention_name>
    <description>&quot;Manual&quot;: manual group acts as a control group where the lens fragmentation are per-formed manually without femtosecond laser assisted lens fragmentation</description>
    <arm_group_label>Manual cataract surgery</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Only the patients who were successfully enrolled in Study #1304 are eligible for this
        follow-up extension study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pavel Stodulka, Dr. Med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gemini clinic, Zlin, Czech Republic 76001</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kasu P Reddy, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>MaxiVision Laser Centre Private Limited, Hyderabad, India</affiliation>
  </overall_official>
  <overall_official>
    <last_name>N Sreelakshmi, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>MaxiVision Laser Centre Private Limited, Hyderabad, India</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Steve Slade, M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Slade &amp; Baker Vision Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Gemini Eye Clinic</name>
      <address>
        <city>Zlin</city>
        <zip>76001</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MaxiVision Laser Centre Private Limited</name>
      <address>
        <city>Hyderabad</city>
        <zip>500082</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Czech Republic</country>
    <country>India</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 6, 2013</study_first_submitted>
  <study_first_submitted_qc>December 23, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 30, 2013</study_first_posted>
  <last_update_submitted>May 22, 2014</last_update_submitted>
  <last_update_submitted_qc>May 22, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 26, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

